使用循证分诊算法降低晚期上皮性卵巢癌初次肿瘤减灭术后90天死亡率
该研究在梅奥诊所比较了实施循证分诊算法后(2012年至2016年7月)与历史对照(2003—2011年)晚期上皮性卵巢癌初次肿瘤减灭术后的结局。当代队列232例患者90天死亡率从8.9%降至2.6%(P=0.002),完全和满意肿瘤减灭率及术后42天内开始化疗比例均提高,3年总生存率从53%升至66%(P<0.001)。作者认为分诊算法与90天死亡率降低及肿瘤学结局改善相关,手术风险评估应纳入实践。
要点
- 实施分诊算法后90天死亡率从8.9%降至2.6%(P=0.002)。
- 3级及以上术后并发症比例从22.3%降至18.3%,差异无统计学显著(P=0.19)。
- 完全肿瘤减灭率从45.5%升至62.5%,满意减灭率从84.5%升至95.3%(P<0.001)。
核心结论
- 使用梅奥分诊算法决定晚期上皮性卵巢癌初次肿瘤减灭术或新辅助化疗后间歇性肿瘤减灭术,与初次肿瘤减灭术后90天死亡率降低及肿瘤学结局改善相关。
- 作者认为手术风险评估是晚期上皮性卵巢癌初始治疗规划的关键环节,应纳入临床实践。
研究设计与样本
- 研究比较梅奥诊所实施循证分诊算法后(当代队列,2012年至2016年7月)与历史初次肿瘤减灭术队列(2003—2011年)IIIC~IV期上皮性卵巢癌患者行初次肿瘤减灭术后的手术并发症和死亡率。
- 当代队列共232名符合纳入标准的女性,平均年龄63.9岁。
主要发现
- 当代队列与历史队列相比,90天死亡率从8.9%降至2.6%(P=0.002),降幅71%。
- 术后30天内Accordion 3级及以上并发症从22.3%降至18.3%(P=0.19),差异无统计学显著。
- 在发生3级及以上并发症的患者中,90天死亡率从历史队列的28.3%降至当代队列的2.4%(P<0.001)。
- 完全肿瘤减灭率从45.5%升至62.5%,满意减灭(残留病灶≤1 cm)率从84.5%升至95.3%(P<0.001)。
- 术后42天内开始化疗的比例从57.4%升至69.8%(P=0.001),3年总生存率从53%升至66%(P<0.001)。
临床怎么用
- 作者认为手术风险评估是晚期上皮性卵巢癌初始治疗规划的关键环节,应纳入临床实践。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate the impact of an evidence-based triage algorithm to decide between primary debulking surgery (PDS) and neoadjuvant chemotherapy followed by interval debulking surgery (NACT/IDS) for advanced epithelial ovarian cancer (EOC). METHODS: Surgical morbidity and mortality (M/M) after PDS for stage IIIC-IV EOC at Mayo Clinic after implementation of the triage algorithm (contemporary cohort, 2012-July 2016) were compared to that of a historic PDS cohort (2003-2011). RESULTS: Mean age of the 232 women who met inclusion criteria in the contemporary cohort was 63.9 years. We observed a 71% decrease in 90-day mortality from 8.9% to 2.6% (P = 0.002) between the contemporary and historic cohorts. Accordion grade 3+ postoperative complications within 30 days after surgery decreased from 22.3% to 18.3% (P = 0.19). Among those with a grade 3+ complication, 90-day mortality rates decreased from 28.3% in the historic cohort to 2.4% in the contemporary cohort (P < 0.001) suggesting patients were better able to tolerate complex surgery. When compared to the historic PDS cohort, oncologic outcomes were also improved in the contemporary PDS cohort. Complete as well as optimal (residual disease ≤1 cm) cytoreduction rates increased (45.5% vs. 62.5% and 84.5% vs. 95.3%, respectively, P < 0.001), and the proportion of women starting chemotherapy within 42 days of surgery increased (57.4% vs. 69.8%, P = 0.001). Three-year overall survival was 53% in the historic cohort and 66% in the contemporary cohort (P < 0.001). CONCLUSIONS: Use of the Mayo triage algorithm for EOC was associated with reduced 90-day mortality after PDS and improved oncologic outcomes. Surgical risk assessment is a critical aspect of treatment planning in the primary management of EOC and should be incorporated into practice.
引用
- Narasimhulu DM, Kumar A, Weaver AL, et al. Using an evidence-based triage algorithm to reduce 90-day mortality after primary debulking surgery for advanced epithelial ovarian cancer. Gynecol Oncol. 2019. PMID: 31402165. doi:10.1016/j.ygyno.2019.08.004
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。